Artificial intelligence is transforming industries at an unprecedented pace, and investors are taking notice.

Several AI stocks have gained significant traction in recent years, offering potential for substantial returns. However, the popularity of NVIDIA (NVDA), a leading provider of graphics processing units (GPUs) for AI applications, has led some to wonder if it’s time to diversify their portfolios by investing in alternative AI-focused companies. One such company is Alphabet’s Verily Life Sciences, which is developing an artificial intelligence platform designed to improve healthcare outcomes. With its cutting-edge technology and focus on personalized medicine, Verily could be a savvy investment opportunity for those looking to capitalize on the growing demand for AI-driven healthcare solutions. Another promising AI stock is NVIDIA’s competitor, Advanced Micro Devices (AMD). While AMD has traditionally focused on the PC gaming market, its recent forays into the AI and machine learning space have garnered significant attention. The company’s EPYC server processors are being used by many AI startups and established organizations alike to power their applications. In contrast to NVIDIA’s dominance in the GPU market, Advanced Micro Devices is taking a more nuanced approach by offering a range of processor architectures that cater to various AI workloads. This diversified strategy could pay dividends for investors who are willing to take on a bit more risk in pursuit of higher returns. While it’s impossible to predict with certainty which AI stock will outperform the others, one thing is clear: the future of artificial intelligence holds immense promise for savvy investors who are willing to take calculated risks.